These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


74 related items for PubMed ID: 16467370

  • 1. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model.
    Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS, Lee SH, Emson PC, Suh YH.
    FASEB J; 2006 Apr; 20(6):729-31. PubMed ID: 16467370
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice.
    Li WZ, Li WP, Yao YY, Zhang W, Yin YY, Wu GC, Gong HL.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):108-15. PubMed ID: 19948164
    [Abstract] [Full Text] [Related]

  • 3. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 4. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M, Ricobaraza A, Frechilla D, Franco R, Pérez-Mediavilla A, Garcia-Osta A.
    J Alzheimers Dis; 2012 Sep 23; 28(3):567-78. PubMed ID: 22045482
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T, Ogino K, Shin RW, Kitamoto T, Kikuchi T, Shimizu N.
    Neurosci Lett; 2010 Jan 22; 469(2):273-7. PubMed ID: 20025930
    [Abstract] [Full Text] [Related]

  • 6. Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic mice.
    Perez Nievas BG, Hammerschmidt T, Kummer MP, Terwel D, Leza JC, Heneka MT.
    J Neurochem; 2011 Jan 22; 116(1):43-52. PubMed ID: 21044080
    [Abstract] [Full Text] [Related]

  • 7. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF.
    Eur J Neurosci; 2006 Jan 22; 23(1):251-60. PubMed ID: 16420434
    [Abstract] [Full Text] [Related]

  • 8. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 22; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 9. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Pérault-Pochat MC, Lafay-Chebassier C.
    J Pharmacol Exp Ther; 2010 Feb 22; 332(2):505-14. PubMed ID: 19889791
    [Abstract] [Full Text] [Related]

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 22; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 11. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767
    [Abstract] [Full Text] [Related]

  • 12. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 01; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 13. Impaired conditioned taste aversion learning in APP transgenic mice.
    Janus C, Welzl H, Hanna A, Lovasic L, Lane N, St George-Hyslop P, Westaway D.
    Neurobiol Aging; 2004 Oct 01; 25(9):1213-9. PubMed ID: 15312967
    [Abstract] [Full Text] [Related]

  • 14. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul 01; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 15. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z, Zhang J, Luo W, Wang W, Li F, Li H, Luo H, Lu J, Zhou J, Wan Y, He R.
    Neurobiol Aging; 2011 Jan 01; 32(1):31-41. PubMed ID: 19879019
    [Abstract] [Full Text] [Related]

  • 16. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.
    J Alzheimers Dis; 2010 Jan 01; 20(1):113-26. PubMed ID: 20164597
    [Abstract] [Full Text] [Related]

  • 17. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC, Sarmad S, Rattray I, Bates TE, Scullion GA, Marsden CA, Barrett DA, Lowe J, Kendall DA.
    Neurobiol Aging; 2009 Jul 01; 30(7):1099-113. PubMed ID: 18023506
    [Abstract] [Full Text] [Related]

  • 18. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
    Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4837-42. PubMed ID: 12697936
    [Abstract] [Full Text] [Related]

  • 19. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
    Jin G, Wang LH, Ji XF, Chi TY, Qi Y, Jiao Q, Xu Q, Zhou XY, Zhang R, Zou LB.
    Neurosci Lett; 2014 Jun 24; 573():58-63. PubMed ID: 24810883
    [Abstract] [Full Text] [Related]

  • 20. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Ding Y, Qiao A, Fan GH.
    Neurobiol Dis; 2010 Aug 24; 39(2):156-68. PubMed ID: 20381617
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.